Global Urinary System Drugs Market Research Report 2017-2022 by Players Regions Product Types & Applications

Global Urinary System Drugs Market Research Report 2017-2022 by Players, Regions, Product Types & Applications

Chapter One Methodology and Data Source

1.1 Methodology/Research Approach

1.1.1 Research Programs/Design

1.1.2 Market Size Estimation

1.1.3 Market Breakdown and Data Triangulation

1.2 Data Source

1.2.1 Secondary Sources

1.2.2 Primary Sources

1.3 Disclaimer

Chapter Two Urinary System Drugs Market Overview

2.1 Market Coverage

2.2 Global Urinary System Drugs Market Sales Volume Revenue and Price 2012-2017

Chapter Three Urinary System Drugs by Key Players 2012-2017

3.1 Global Urinary System Drugs Sales Volume Market Share by Key Players 2012-2017

3.2 Global Urinary System Drugs Revenue Share by Key Players 2012-2017

3.3 Global Key Players Urinary System Drugs Key Product Model and Market Performance

3.4 Global Key Players Urinary System Drugs Key Target Consumers and Market Performance

Chapter Four Urinary System Drugs by Regions 2012-2017

4.1 Global Urinary System Drugs Sales Market Share by Regions 2012-2017

4.2 Global Urinary System Drugs Revenue Market Share by Regions 2012-2017

4.3 Global Urinary System Drugs Price by Regions 2012-2017

4.4 North America

4.4.1 United States

4.4.2 Canada

4.5 Latin America

4.5.1 Mexico

4.5.2 Brazil

4.5.3 Argentina

4.5.4 Others in Latin America

4.6 Europe

4.6.1 Germany

4.6.2 United Kingdom

4.6.3 France

4.6.4 Italy

4.6.5 Spain

4.6.6 Russia

4.6.7 Netherland

4.6.8 Others in Europe

4.7 Asia & Pacific

4.7.1 China

4.7.2 Japan

4.7.3 India

4.7.4 Korea

4.7.5 Australia

4.7.6 Southeast Asia

4.7.6.1 Indonesia

4.7.6.2 Thailand

4.7.6.3 Philippines

4.7.6.4 Vietnam

4.7.6.5 Singapore

4.7.6.6 Malaysia

4.7.6.7 Others in Southeast Asia

4.8 Africa & Middle East

4.8.1 South Africa

4.8.2 Egypt

4.8.3 Turkey

4.8.4 Saudi Arabia

4.8.5 Iran

4.8.6 Others in Africa & Middle East

Chapter Five Urinary System Drugs Market by Product Types

5.1 Urinary System Drugs, by Loop diuretics 2012-2017

5.1.1 Global Urinary System Drugs Sales Market Share by Loop diuretics 2012-2017

5.1.2 Global Urinary System Drugs Revenue Market Share by Loop diuretics 2012-2017

5.1.3 Global Urinary System Drugs Price by Loop diuretics 2012-2017

5.1.4 Furosemide

5.1.5 Bumetanide

5.1.6 Bumetanide

5.1.7 Ethacrynic Acid

5.1.8 Etozolin

5.2 Urinary System Drugs, by Thiazide diuretic 2012-2017

5.2.1 Global Urinary System Drugs Sales Market Share by Thiazide diuretic 2012-2017

5.2.2 Global Urinary System Drugs Revenue Market Share by Thiazide diuretic 2012-2017

5.2.3 Global Urinary System Drugs Price by Thiazide diuretic 2012-2017

5.2.4 Hydrochlorothiazide

5.2.5 Bendrofluazide

5.2.6 Hdyroflumethiazide

5.2.7 Polythiazide

5.2.8 Trichlormethiazide

5.3 Urinary System Drugs, by Thiazide-like diuretics 2012-2017

5.3.1 Global Urinary System Drugs Sales Market Share by Thiazide-like diuretics 2012-2017

5.3.2 Global Urinary System Drugs Revenue Market Share by Thiazide-like diuretics 2012-2017

5.3.3 Global Urinary System Drugs Price by Thiazide-like diuretics 2012-2017

5.3.4 Quinethazone

5.3.5 Clopamide

5.3.6 Chlorthalidone

5.3.7 Mefruside

5.3.8 Clofenamide

5.4 Urinary System Drugs, by potassium-sparing diuretics 2012-2017

5.4.1 Global Urinary System Drugs Sales Market Share by potassium-sparing diuretics 2012-2017

5.4.2 Global Urinary System Drugs Revenue Market Share by potassium-sparing diuretics 2012-2017

5.4.3 Global Urinary System Drugs Price by potassium-sparing diuretics 2012-2017

5.4.4 Amiloride

5.4.5 Triamterene

5.4.6 Spironolactone

5.4.7 Eplerenone

5.4.8 Canrenoate Potassium

5.5 Urinary System Drugs, by Vasopressin receptor antagonis 2012-2017

5.5.1 Global Urinary System Drugs Sales Market Share by Vasopressin receptor antagonis 2012-2017

5.5.2 Global Urinary System Drugs Revenue Market Share by Vasopressin receptor antagonis 2012-2017

5.5.3 Global Urinary System Drugs Price by Vasopressin receptor antagonis 2012-2017

5.5.4 Conivaptan

5.5.5 Mozavaptan

5.5.6 Tolvaptan

5.5.7 Demeclocycline

Chapter Six Global Key Players Profile

6.1 ALVOGEN MALTA

6.1.1 ALVOGEN MALTA Company Details and Competitors

6.1.2 ALVOGEN MALTA Key Urinary System Drugs Models and Performance

6.1.3 ALVOGEN MALTA Urinary System Drugs Business SWOT Analysis and Forecast

6.1.4 ALVOGEN MALTA Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin

6.2 APOTEX INC

6.2.1 APOTEX INC Company Details and Competitors

6.2.2 APOTEX INC Key Urinary System Drugs Models and Performance

6.2.3 APOTEX INC Urinary System Drugs Business SWOT Analysis and Forecast

6.2.4 APOTEX INC Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin

6.3 ARBOR PHARMS LLC

6.3.1 ARBOR PHARMS LLC Company Details and Competitors

6.3.2 ARBOR PHARMS LLC Key Urinary System Drugs Models and Performance

6.3.3 ARBOR PHARMS LLC Urinary System Drugs Business SWOT Analysis and Forecast

6.3.4 ARBOR PHARMS LLC Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin

6.4 ASTRAZENECA

6.4.1 ASTRAZENECA Company Details and Competitors

6.4.2 ASTRAZENECA Key Urinary System Drugs Models and Performance

6.4.3 ASTRAZENECA Urinary System Drugs Business SWOT Analysis and Forecast

6.4.4 ASTRAZENECA Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin

6.5 ATHENEX INC

6.5.1 ATHENEX INC Company Details and Competitors

6.5.2 ATHENEX INC Key Urinary System Drugs Models and Performance

6.5.3 ATHENEX INC Urinary System Drugs Business SWOT Analysis and Forecast

6.5.4 ATHENEX INC Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin

6.6 BARR

6.6.1 BARR Company Details and Competitors

6.6.2 BARR Key Urinary System Drugs Models and Performance

6.6.3 BARR Urinary System Drugs Business SWOT Analysis and Forecast

6.6.4 BARR Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin

6.7 CLARIS

6.7.1 CLARIS Company Details and Competitors

6.7.2 CLARIS Key Urinary System Drugs Models and Performance

6.7.3 CLARIS Urinary System Drugs Business SWOT Analysis and Forecast

6.7.4 CLARIS Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin

6.8 DAIICHI SANKYO

6.8.1 DAIICHI SANKYO Company Details and Competitors

6.8.2 DAIICHI SANKYO Key Urinary System Drugs Models and Performance

6.8.3 DAIICHI SANKYO Urinary System Drugs Business SWOT Analysis and Forecast

6.8.4 DAIICHI SANKYO Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin

6.9 DR REDDYS LABS LTD

6.9.1 DR REDDYS LABS LTD Company Details and Competitors

6.9.2 DR REDDYS LABS LTD Key Urinary System Drugs Models and Performance

6.9.3 DR REDDYS LABS LTD Urinary System Drugs Business SWOT Analysis and Forecast

6.9.4 DR REDDYS LABS LTD Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin

6.10 EDENBRIDGE PHARMS

6.10.1 EDENBRIDGE PHARMS Company Details and Competitors

6.10.2 EDENBRIDGE PHARMS Key Urinary System Drugs Models and Performance

6.10.3 EDENBRIDGE PHARMS Urinary System Drugs Business SWOT Analysis and Forecast

6.10.4 EDENBRIDGE PHARMS Urinary System Drugs Sales Volume Revenue Price Cost and Gross Margin

6.11 FRESENIUS KABI USA

6.12 GD SEARLE LLC

6.13 HOSPIRA

6.14 IPCA LABS LTD

6.15 IVAX SUB TEVA PHARMS

6.16 LUPIN LTD

6.17 MACLEODS PHARMS LTD

6.18 MERCK SHARP DOHME

6.19 MYLAN

6.20 PAR PHARM INC

6.21 PFIZER PHARMS

6.22 PRINSTON INC

6.23 SANDOZ

6.24 SANOFI AVENTIS US

6.25 SUN PHARM INDS INC

6.26 TEVA PHARMS

6.27 TORRENT PHARMS LTD

6.28 WATSON LABS

6.29 WEST-WARD PHARMS INT

6.30 WOCKHARDT

Chapter Seven Urinary System Drugs by Appliance 2012-2017

7.1 Global Urinary System Drugs Sales Market Share by Appliance 2012-2017

7.2 Urology Surgery

7.3 department of nephropathy

7.4 Liver disease division

7.5 Hospital

7.6 Clinic

7.7 Consuming Habit and Preference

Chapter Eight Industry Chain and Supply Chain

8.1 Urinary System Drugs Industry Chain Structure

8.1.1 R&D

8.1.2 Raw Materials (Components)

8.1.3 Manufacturing Plants

8.1.4 Regional Trading (Import Export and Local Sales)

8.1.5 Online Sales Channel

8.1.6 Offline Channel

8.1.7 End Users

8.2 Urinary System Drugs Manufacturing

8.2.1 Key Components

8.2.2 Assembly Manufacturing

8.3 Consumer Preference

8.4 Behavioral Habits

8.5 Marketing Environment

Chapter Nine Global Urinary System Drugs Market Size (Sales and Revenue) Forecast (2017-2022)

9.1 Global Urinary System Drugs Sales (), Revenue (Million USD) Forecast (2017-2022)

9.2 Global Urinary System Drugs Sales () Forecast by Regions (2017-2022)

9.3 Global Urinary System Drugs Sales () Forecast by Application (2017-2022)

9.4 Global Urinary System Drugs Sales () Forecast by Loop diuretics (2017-2022)

9.5 Global Urinary System Drugs Sales () Forecast by Thiazide diuretic (2017-2022)

9.6 Global Urinary System Drugs Sales () Forecast by Thiazide-like diuretics (2017-2022)

9.7 Global Urinary System Drugs Sales () Forecast by potassium-sparing diuretics (2017-2022)

9.8 Global Urinary System Drugs Sales () Forecast by Vasopressin receptor antagonis (2017-2022)

Chapter Ten Development Trend and Research Conclusion

10.1 Development Trend

10.2 Research Conclusion

Table Global Urinary System Drugs Sales Volume (), Revenue (Million USD) and Price ()(2012-2017)

Figure Global Urinary System Drugs Revenue (Million USD) and Growth Rate (2012-2017)

Figure Global Urinary System Drugs Sales Volume () and Growth Rate (2012-2017)

Table Global Urinary System Drugs Sales Volume () by Key Players (2012-2017)

Table Global Urinary System Drugs Sales Volume Market Share by Key Players (2012-2017)

Figure Global Urinary System Drugs Sales Volume Market Share by Key Players 2016

Figure Global Urinary System Drugs Sales Volume Market Share by Key Players 2017

Table Global Urinary System Drugs Revenue (Million USD) by Key Players (2012-2017)

Table Global Urinary System Drugs Revenue Market Share by Key Players (2012-2017)

Figure Global Urinary System Drugs Revenue Market Share by Key Players 2016

Figure Global Urinary System Drugs Revenue Market Share by Key Players 2017

Table Global Key Players Key Product Model and Market Performance

Table Global Key Players Key Target Consumers and Market Performance

Table Global Urinary System Drugs Sales () by Regions (2012-2017)

Table Global Urinary System Drugs Sales Share by Regions (2012-2017)

Figure Global Urinary System Drugs Sales Market Share by Regions in 2016

Figure Global Urinary System Drugs Sales Market Share by Regions in 2017

Table Global Urinary System Drugs Revenue (Million USD) by Regions (2012-2017)

Table Global Urinary System Drugs Revenue Market Share by Regions (2012-2017)

Figure Global Urinary System Drugs Revenue Market Share by Regions in 2016

Figure Global Urinary System Drugs Revenue Market Share by Regions in 2017

Table Global Urinary System Drugs Price () by Regions (2012-2017)

Table North America Urinary System Drugs Sales () by Regions (2012-2017)

Table North America Urinary System Drugs Revenue (Million USD) by Regions (2012-2017)

Table North America Urinary System Drugs Sales Volume () by Key Players 2012-2017

Figure North America Urinary System Drugs Sales () and Growth Rate (2012-2017)

Table Latin America Urinary System Drugs Sales () by Regions (2012-2017)

Table Latin America Urinary System Drugs Revenue (Million USD) by Regions (2012-2017)

Table Latin America Urinary System Drugs Sales Volume () by Key Players (2012-2017)

Figure Latin America Urinary System Drugs Sales () and Growth Rate (2012-2017)

Table Europe Urinary System Drugs Sales () by Regions (2012-2017)

Table Europe Urinary System Drugs Revenue (Million USD) by Regions (2012-2017)

Table Europe Urinary System Drugs Sales Volume () by Key Players (2012-2017)

Figure Europe Urinary System Drugs Sales () and Growth Rate (2012-2017)

Table Asia & Pacific Urinary System Drugs Sales () by Regions (2012-2017)

Table Asia & Pacific Urinary System Drugs Revenue (Million USD) by Regions (2012-2017)

Table Asia & Pacific Urinary System Drugs Sales Volume () by Key Players (2012-2017)

Figure Asia & Pacific Urinary System Drugs Sales () and Growth Rate (2012-2017)

Table Africa & Middle East Urinary System Drugs Sales () by Regions (2012-2017)

Table Africa & Middle East Urinary System Drugs Revenue (Million USD) by Regions (2012-2017)

Table Africa & Middle East Urinary System Drugs Sales Volume () by Key Players (2012-2017)

Figure Africa & Middle East Urinary System Drugs Sales () and Growth Rate (2012-2017)

Table Global Urinary System Drugs Sales () by Loop diuretics (2012-2017)

Table Global Urinary System Drugs Sales Market Share by Loop diuretics (2012-2017)

Figure Global Urinary System Drugs Sales Market Share by Loop diuretics in 2016

Table Global Urinary System Drugs Revenue (Million USD) by Loop diuretics (2012-2017)

Table Global Urinary System Drugs Revenue Market Share by Loop diuretics (2012-2017)

Figure Global Urinary System Drugs Revenue Market Share by Loop diuretics in 2016

Table Global Urinary System Drugs Price () by Loop diuretics (2012-2017)

Table Top Players of Furosemide Urinary System Drugs Products List

Figure Global Furosemide Urinary System Drugs Sales () and Growth Rate (2012-2017)

Table Top Players of Bumetanide Urinary System Drugs Products List

Figure Global Bumetanide Urinary System Drugs Sales () and Growth Rate (2012-2017)

Table Top Players of Bumetanide Urinary System Drugs Products List

Figure Global Bumetanide Urinary System Drugs Sales () and Growth Rate (2012-2017)

Table Top Players of Ethacrynic Acid Urinary System Drugs Products List

Figure Global Ethacrynic Acid Urinary System Drugs Sales () and Growth Rate (2012-2017)

Table Top Players of Etozolin Urinary System Drugs Products List

Figure Global Etozolin Urinary System Drugs Sales () and Growth Rate (2012-2017)

Table Global Urinary System Drugs Sales () by Thiazide diuretic (2012-2017)

Table Global Urinary System Drugs Sales Market Share by Thiazide diuretic (2012-2017)

Figure Global Urinary System Drugs Sales Market Share by Thiazide diuretic in 2016

Table Global Urinary System Drugs Revenue (Million USD) by Thiazide diuretic (2012-2017)

Table Global Urinary System Drugs Revenue Market Share by Thiazide diuretic (2012-2017)

Figure Global Urinary System Drugs Revenue Market Share by Thiazide diuretic in 2016

Table Global Urinary System Drugs Price () by Thiazide diuretic (2012-2017)

Table Top Players of Hydrochlorothiazide Urinary System Drugs Products List

Figure Global Hydrochlorothiazide Urinary System Drugs Sales () and Growth Rate (2012-2017)

Table Top Players of Bendrofluazide Urinary System Drugs Products List

Figure Global Bendrofluazide Urinary System Drugs Sales () and Growth Rate (2012-2017)

Table Top Players of Hdyroflumethiazide Urinary System Drugs Products List

Figure Global Hdyroflumethiazide Urinary System Drugs Sales () and Growth Rate (2012-2017)

Table Top Players of Polythiazide Urinary System Drugs Products List

Figure Global Polythiazide Urinary System Drugs Sales () and Growth Rate (2012-2017)

Table Top Players of Trichlormethiazide Urinary System Drugs Products List

Figure Global Trichlormethiazide Urinary System Drugs Sales () and Growth Rate (2012-2017)

Table Global Urinary System Drugs Sales () by Thiazide-like diuretics (2012-2017)

Table Global Urinary System Drugs Sales Market Share by Thiazide-like diuretics (2012-2017)

Figure Global Urinary System Drugs Sales Market Share by Thiazide-like diuretics in 2016

Table Global Urinary System Drugs Revenue (Million USD) by Thiazide-like diuretics (2012-2017)

Table Global Urinary System Drugs Revenue Market Share by Thiazide-like diuretics (2012-2017)

Figure Global Urinary System Drugs Revenue Market Share by Thiazide-like diuretics in 2016

Table Global Urinary System Drugs Price () by Thiazide-like diuretics (2012-2017)

Table Top Players of Quinethazone Urinary System Drugs Products List

Figure Global Quinethazone Urinary System Drugs Sales () and Growth Rate (2012-2017)

Table Top Players of Clopamide Urinary System Drugs Products List

Figure Global Clopamide Urinary System Drugs Sales () and Growth Rate (2012-2017)

Table Top Players of Chlorthalidone Urinary System Drugs Products List

Figure Global Chlorthalidone Urinary System Drugs Sales () and Growth Rate (2012-2017)

Table Top Players of Mefruside Urinary System Drugs Products List

Figure Global Mefruside Urinary System Drugs Sales () and Growth Rate (2012-2017)

Table Top Players of Clofenamide Urinary System Drugs Products List

Figure Global Clofenamide Urinary System Drugs Sales () and Growth Rate (2012-2017)

Table Global Urinary System Drugs Sales () by potassium-sparing diuretics (2012-2017)

Table Global Urinary System Drugs Sales Market Share by potassium-sparing diuretics (2012-2017)

Figure Global Urinary System Drugs Sales Market Share by potassium-sparing diuretics in 2016

Table Global Urinary System Drugs Revenue (Million USD) by potassium-sparing diuretics (2012-2017)

Table Global Urinary System Drugs Revenue Market Share by potassium-sparing diuretics (2012-2017)

Figure Global Urinary System Drugs Revenue Market Share by potassium-sparing diuretics in 2016

Table Global Urinary System Drugs Price () by potassium-sparing diuretics (2012-2017)

Table Top Players of Amiloride Urinary System Drugs Products List

Figure Global Amiloride Urinary System Drugs Sales () and Growth Rate (2012-2017)

Table Top Players of Triamterene Urinary System Drugs Products List

Figure Global Triamterene Urinary System Drugs Sales () and Growth Rate (2012-2017)

Table Top Players of Spironolactone Urinary System Drugs Products List

Figure Global Spironolactone Urinary System Drugs Sales () and Growth Rate (2012-2017)

Table Top Players of Eplerenone Urinary System Drugs Products List

Figure Global Eplerenone Urinary System Drugs Sales () and Growth Rate (2012-2017)

Table Top Players of Canrenoate Potassium Urinary System Drugs Products List

Figure Global Canrenoate Potassium Urinary System Drugs Sales () and Growth Rate (2012-2017)

Table Global Urinary System Drugs Sales () by Vasopressin receptor antagonis (2012-2017)

Table Global Urinary System Drugs Sales Market Share by Vasopressin receptor antagonis (2012-2017)

Figure Global Urinary System Drugs Sales Market Share by Vasopressin receptor antagonis in 2016

Table Global Urinary System Drugs Revenue (Million USD) by Vasopressin receptor antagonis (2012-2017)

Table Global Urinary System Drugs Revenue Market Share by Vasopressin receptor antagonis (2012-2017)

Figure Global Urinary System Drugs Revenue Market Share by Vasopressin receptor antagonis in 2016

Table Global Urinary System Drugs Price () by Vasopressin receptor antagonis (2012-2017)

Table Top Players of Conivaptan Urinary System Drugs Products List

Figure Global Conivaptan Urinary System Drugs Sales () and Growth Rate (2012-2017)

Table Top Players of Mozavaptan Urinary System Drugs Products List

Figure Global Mozavaptan Urinary System Drugs Sales () and Growth Rate (2012-2017)

Table Top Players of Tolvaptan Urinary System Drugs Products List

Figure Global Tolvaptan Urinary System Drugs Sales () and Growth Rate (2012-2017)

Table Top Players of Demeclocycline Urinary System Drugs Products List

Figure Global Demeclocycline Urinary System Drugs Sales () and Growth Rate (2012-2017)

Table ALVOGEN MALTA Company Details and Competitors

Table ALVOGEN MALTA Key Urinary System Drugs Models and Performance

Table ALVOGEN MALTA Urinary System Drugs Business SWOT Analysis and Forecast

Table ALVOGEN MALTA Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Figure ALVOGEN MALTA Urinary System Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)

Figure ALVOGEN MALTA Urinary System Drugs Sales Market Share (%) in Global (2012-2017)

Figure ALVOGEN MALTA Urinary System Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)

Figure ALVOGEN MALTA Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)

Table APOTEX INC Company Details and Competitors

Table APOTEX INC Key Urinary System Drugs Models and Performance

Table APOTEX INC Urinary System Drugs Business SWOT Analysis and Forecast

Table APOTEX INC Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Figure APOTEX INC Urinary System Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)

Figure APOTEX INC Urinary System Drugs Sales Market Share (%) in Global (2012-2017)

Figure APOTEX INC Urinary System Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)

Figure APOTEX INC Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)

Table ARBOR PHARMS LLC Company Details and Competitors

Table ARBOR PHARMS LLC Key Urinary System Drugs Models and Performance

Table ARBOR PHARMS LLC Urinary System Drugs Business SWOT Analysis and Forecast

Table ARBOR PHARMS LLC Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Figure ARBOR PHARMS LLC Urinary System Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)

Figure ARBOR PHARMS LLC Urinary System Drugs Sales Market Share (%) in Global (2012-2017)

Figure ARBOR PHARMS LLC Urinary System Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)

Figure ARBOR PHARMS LLC Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)

Table ASTRAZENECA Company Details and Competitors

Table ASTRAZENECA Key Urinary System Drugs Models and Performance

Table ASTRAZENECA Urinary System Drugs Business SWOT Analysis and Forecast

Table ASTRAZENECA Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Figure ASTRAZENECA Urinary System Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)

Figure ASTRAZENECA Urinary System Drugs Sales Market Share (%) in Global (2012-2017)

Figure ASTRAZENECA Urinary System Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)

Figure ASTRAZENECA Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)

Table ATHENEX INC Company Details and Competitors

Table ATHENEX INC Key Urinary System Drugs Models and Performance

Table ATHENEX INC Urinary System Drugs Business SWOT Analysis and Forecast

Table ATHENEX INC Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Figure ATHENEX INC Urinary System Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)

Figure ATHENEX INC Urinary System Drugs Sales Market Share (%) in Global (2012-2017)

Figure ATHENEX INC Urinary System Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)

Figure ATHENEX INC Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)

Table BARR Company Details and Competitors

Table BARR Key Urinary System Drugs Models and Performance

Table BARR Urinary System Drugs Business SWOT Analysis and Forecast

Table BARR Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Figure BARR Urinary System Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)

Figure BARR Urinary System Drugs Sales Market Share (%) in Global (2012-2017)

Figure BARR Urinary System Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)

Figure BARR Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)

Table CLARIS Company Details and Competitors

Table CLARIS Key Urinary System Drugs Models and Performance

Table CLARIS Urinary System Drugs Business SWOT Analysis and Forecast

Table CLARIS Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Figure CLARIS Urinary System Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)

Figure CLARIS Urinary System Drugs Sales Market Share (%) in Global (2012-2017)

Figure CLARIS Urinary System Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)

Figure CLARIS Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)

Table DAIICHI SANKYO Company Details and Competitors

Table DAIICHI SANKYO Key Urinary System Drugs Models and Performance

Table DAIICHI SANKYO Urinary System Drugs Business SWOT Analysis and Forecast

Table DAIICHI SANKYO Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Figure DAIICHI SANKYO Urinary System Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)

Figure DAIICHI SANKYO Urinary System Drugs Sales Market Share (%) in Global (2012-2017)

Figure DAIICHI SANKYO Urinary System Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)

Figure DAIICHI SANKYO Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)

Table DR REDDYS LABS LTD Company Details and Competitors

Table DR REDDYS LABS LTD Key Urinary System Drugs Models and Performance

Table DR REDDYS LABS LTD Urinary System Drugs Business SWOT Analysis and Forecast

Table DR REDDYS LABS LTD Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Figure DR REDDYS LABS LTD Urinary System Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)

Figure DR REDDYS LABS LTD Urinary System Drugs Sales Market Share (%) in Global (2012-2017)

Figure DR REDDYS LABS LTD Urinary System Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)

Figure DR REDDYS LABS LTD Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)

Table EDENBRIDGE PHARMS Company Details and Competitors

Table EDENBRIDGE PHARMS Key Urinary System Drugs Models and Performance

Table EDENBRIDGE PHARMS Urinary System Drugs Business SWOT Analysis and Forecast

Table EDENBRIDGE PHARMS Urinary System Drugs Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Figure EDENBRIDGE PHARMS Urinary System Drugs Sales(Million Unit) and Growth Rate (%)(2012-2017)

Figure EDENBRIDGE PHARMS Urinary System Drugs Sales Market Share (%) in Global (2012-2017)

Figure EDENBRIDGE PHARMS Urinary System Drugs Sales Revenue(Million USD) and Growth Rate (%)(2012-2017)

Figure EDENBRIDGE PHARMS Urinary System Drugs Revenue Market Share (%) in Global (2012-2017)

Table FRESENIUS KABI USA Company Details and Competitors

Table GD SEARLE LLC Company Details and Competitors

Table HOSPIRA Company Details and Competitors

Table IPCA LABS LTD Company Details and Competitors

Table IVAX SUB TEVA PHARMS Company Details and Competitors

Table LUPIN LTD Company Details and Competitors

Table MACLEODS PHARMS LTD Company Details and Competitors

Table MERCK SHARP DOHME Company Details and Competitors

Table MYLAN Company Details and Competitors

Table PAR PHARM INC Company Details and Competitors

Table PFIZER PHARMS Company Details and Competitors

Table PRINSTON INC Company Details and Competitors

Table SANDOZ Company Details and Competitors

Table SANOFI AVENTIS US Company Details and Competitors

Table SUN PHARM INDS INC Company Details and Competitors

Table TEVA PHARMS Company Details and Competitors

Table TORRENT PHARMS LTD Company Details and Competitors

Table WATSON LABS Company Details and Competitors

Table WEST-WARD PHARMS INT Company Details and Competitors

Table WOCKHARDT Company Details and Competitors

Table Global Urinary System Drugs Sales () by Appliance (2012-2017)

Figure Global Urinary System Drugs Sales Market Share by Appliance (2012-2017)

Figure Global Urinary System Drugs Sales Market Share by Appliance in 2016

Figure Global Urology Surgery Urinary System Drugs Sales () and Growth Rate (2012-2017)

Figure Global department of nephropathy Urinary System Drugs Sales () and Growth Rate (2012-2017)

Figure Global Liver disease division Urinary System Drugs Sales () and Growth Rate (2012-2017)

Figure Global Hospital Urinary System Drugs Sales () and Growth Rate (2012-2017)

Figure Global Clinic Urinary System Drugs Sales () and Growth Rate (2012-2017)

Figure Global Urinary System Drugs Sales () and Growth Rate (%) Forecast (2017-2022)

Figure Global Urinary System Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Global Urinary System Drugs Price () Trend Forecast (2017-2022)

Table Global Urinary System Drugs Sales () Forecast by Regions (2017-2022)

Table Global Urinary System Drugs Sales Volume Share Forecast by Regions (2017-2022)

Figure Global Urinary System Drugs Sales Volume Share Forecast by Regions (2017-2022)

Figure Global Urinary System Drugs Sales Volume Share Forecast by Regions in 2022

Table Global Urinary System Drugs Sales () Forecast by Application (2017-2022)

Figure Global Urinary System Drugs Sales Volume Market Share Forecast by Application (2017-2022)

Figure Global Urinary System Drugs Sales Volume Market Share Forecast by Application in 2022

Table Global Urinary System Drugs Sales () Forecast by Loop diuretics (2017-2022)

Figure Global Urinary System Drugs Sales () Forecast by Loop diuretics (2017-2022)

Figure Global Urinary System Drugs Sales Volume Market Share Forecast by Loop diuretics in 2022

Table Global Urinary System Drugs Sales () Forecast by Thiazide diuretic (2017-2022)

Figure Global Urinary System Drugs Sales () Forecast by Thiazide diuretic (2017-2022)

Figure Global Urinary System Drugs Sales Volume Market Share Forecast by Thiazide diuretic in 2022

Table Global Urinary System Drugs Sales () Forecast by Thiazide-like diuretics (2017-2022)

Figure Global Urinary System Drugs Sales () Forecast by Thiazide-like diuretics (2017-2022)

Figure Global Urinary System Drugs Sales Volume Market Share Forecast by Thiazide-like diuretics in 2022

Table Global Urinary System Drugs Sales () Forecast by potassium-sparing diuretics (2017-2022)

Figure Global Urinary System Drugs Sales () Forecast by potassium-sparing diuretics (2017-2022)

Figure Global Urinary System Drugs Sales Volume Market Share Forecast by potassium-sparing diuretics in 2022

Table Global Urinary System Drugs Sales () Forecast by Vasopressin receptor antagonis (2017-2022)

Figure Global Urinary System Drugs Sales () Forecast by Vasopressin receptor antagonis (2017-2022)

Figure Global Urinary System Drugs Sales Volume Market Share Forecast by Vasopressin receptor antagonis in 2022